A new biomarker has been discovered to help determine which colon cancer patients may benefit from immunotherapy, expanding treatment options for around 5% of patients. The biomarker, CTHRC1(+), identifies cells in the tumor microenvironment that can predict treatment response and disease outcomes.
A new study confirms a direct link between good physical fitness and reduced risk of suffering from over 30 diseases. Individuals with high genetic predisposition to be physically fit exhibit lower risks of cardiovascular conditions, diabetes, and asthma, while also showing better health in metabolic and inflammatory aspects.
Researchers have discovered a pathway that makes estrogen receptor-positive breast cancer tumors responsive to immunotherapy. By inhibiting the estrogen receptor, LCOR molecule activation is enabled, allowing tumor cells to become visible to the immune system.
A recent study published in Environment International reveals that air pollution during pregnancy is associated with slower brain maturation in newborns. The study, conducted using magnetic resonance imaging (MRI), found a clear correlation between higher maternal exposure to PM2.5 and lower myelination levels in newborn brains.
A study of 73,000 university students reveals strong associations between childhood traumatic events, transgender identity, and suicidal thoughts. Transgender students are 2.4 times more likely to experience suicidal ideation, emphasizing the need for targeted prevention strategies.
A novel approach combining chemotherapy, immunotherapy, and a MET inhibitor enhances treatment response and limits tumor growth in small cell lung cancer (SCLC). The strategy slows tumor progression and improves survival outcomes by facilitating the effectiveness of standard treatment.
A study has identified 10 metabolites altered in COPD patients, potentially leading to early detection and treatment. The biomarkers showed high sensitivity and specificity in distinguishing COPD patients from healthy individuals.
Study identifies genes functional in fetal brain stem cells linked to various brain diseases, including autism, depression, and Alzheimer's. Understanding these mechanisms can lead to targeted therapies and personalized treatments.
Researchers discovered that amino acids constantly communicate through a dynamic network within cells, modulating the cellular response to different stimuli. This knowledge may lead to more accurate and targeted treatments for various diseases, avoiding unwanted side effects.
The study identifies the brain circuit controlling associations between stimuli and allows for indirect associations. The amygdala plays a crucial role in linking olfactory and taste stimuli.
A study reveals that Galectin-1 protein, located in fibroblast nuclei, promotes tumor growth and resistance to treatment. The protein regulates gene expression at a specific level, activating KRAS, a key driver of uncontrolled growth and tumor aggressiveness.
Researchers have validated a blood test for early detection of Alzheimer's disease, achieving over 90% accuracy in hospital patients. The test uses a biomarker called phospho-tau217 and has the potential to reduce costs associated with current diagnostic tests, improving access to care and treatment.
Researchers have identified new gateways for drugs to modulate proteins regulating cellular activity. These discoveries may facilitate the creation of new medications or improve existing ones, leading to more targeted therapies and reduced side effects.
Researchers developed a new approach to strengthen NK cells' fight against tumors by using CRISPR/Cas9 to eliminate the SMAD4 gene, making them resistant to TGF-β and Activin A molecules. The modified cells showed greater capacity to control tumor growth in both laboratory models and mice.
A study has established the importance of immunoglobulin A in generating a response to pneumonia vaccines. The research found that poor regulation of gut microbiota can lead to an inadequate immune response, leaving individuals vulnerable to respiratory infections.
A study led by Dr. Rodrigo Quian Quiroga has confirmed that individual neurons represent concepts learned in any context, enabling abstract relationships and human intelligence. This finding contradicts previous research on animals, where memories were thought to be stored in different groups of neurons.
A recent study published in Frontiers in Psychiatry reveals a strong link between antidepressant use and weight gain, with an average 2% increase in body weight among participants. The study highlights the need to consider this association when prescribing antidepressants and monitor weight changes accordingly.
A recent study has identified that the neuronal subtype responds best to immunotherapy, while other subtypes exhibit lower response rates. The researchers developed a machine-learning algorithm using large public data sets to predict treatment response based on tumor mutational burden and immune cell infiltration.
A phase 1/2 clinical trial has demonstrated the safety and effectiveness of the AEF0217 molecule in improving cognitive function in people with Down syndrome. Measured outcomes showed significant improvements in behavioral skills, social interactions, and cognitive flexibility.
Consuming 20-30% of daily energy at breakfast is associated with lower body mass index, smaller waist circumference, significantly lower triglyceride levels, and higher HDL cholesterol. A high-quality breakfast with proper balance of proteins, fats, fiber, and nutrients also contributes to reducing cardiovascular risk factors.
A study published in Cardiovascular Diabetology found that higher blood glucose levels at admission significantly increase the risk of a poor functional prognosis or death within three months of an ischemic stroke. The study revealed that even a 10% increase in glucose levels raises the risk by 7%, and mortality risk by 88%.
Researchers have identified microproteins exclusive to liver tumors that can stimulate the immune system against cancer cells. These small molecules, generated from previously non-coding genes, could be used to develop new treatments, including vaccines that stop or reduce tumor growth.
A new study has identified two proteins that play a vital role in modulating cell responses in schizophrenia. The researchers found that these proteins can be targeted to develop drugs that address specific symptoms of the disease, potentially leading to more effective and personalized treatments.
A new oral treatment, E-52862, has been found to reduce the severity and duration of mild COVID-19 symptoms. The study involved 120 volunteers and showed that the drug can be administered on an outpatient basis.
Researchers propose conjugating a cell-penetrating peptide to oxaliplatin to overcome chemotherapy resistance in colorectal cancer. The new approach reduces platinum accumulation in tumour microenvironment and healthy tissues.
A recent study analyzing over 93,000 cases reveals a direct link between childhood trauma and the risk of developing a mental disorder in adulthood. The study highlights the importance of treating psychological trauma in patients and investing in prevention programs to reduce the risk of suffering a mental disorder.
A new therapy has been discovered to overcome treatment resistance in aggressive breast cancer by targeting fibroblasts and enhancing the immune response. The therapy, FAP-IL2v, binds to fibroblast-expressed molecules, allowing the immune system to break through the tumor's protective microenvironment and eliminate cancer cells.
Researchers have discovered an essential role of LCOR in enabling cancer cells to present tumour antigens, making them visible to the immune system. This approach increases the success of immunotherapy in triple-negative breast cancer, a subtype with low treatment response rates.
A study found that people living within 300 meters of green spaces have a 16% lower risk of ischemic stroke. The researchers suggest that the current European Union air pollution limits for nitrogen dioxide and particulate matter need to be reconsidered due to the direct relationship between exposure to these pollutants and stroke risk.
Scientists have discovered how neurotransmitters and proteins interact to trigger neuronal responses in the brain, with implications for understanding mood disorders and addictions. The study reveals small changes in protein connections control cellular responses, enabling precise regulation of neurotransmitter effects.
A study found that higher omega-3 acid levels in the blood are associated with a significant increase in life expectancy, similar to quitting smoking. The researchers analyzed data from over 2,200 people aged 65 and found that four types of fatty acids, including omega-3, can predict mortality risk.
Researchers at IMIM-Hospital del Mar and CIBERONC discover a low-toxicity treatment combining chemotherapy and BRAF inhibitors eradicates malignant melanoma by preventing DNA repair. The strategy offers a new therapeutic perspective for patients with BRAF oncogene mutations.
A study by researchers from King's College London and IMIM found that 6.4% of Europeans suffer from depression, with higher rates in economically developed nations and varying rates across countries. The study suggests that demographic and socio-political factors contribute to the differences in prevalence.
Researchers found that COVID-19 vaccines pre-prepared in syringes can be safely transported under minor precautions, with messenger RNA remaining stable for at least three hours. The study aims to streamline vaccination processes, particularly in rural and less developed areas.
Research reveals brain changes in obese children, similar to those seen in OCD and Prader-Willi syndrome, causing obsession with food and anxiety. The study suggests a multidisciplinary approach is needed for treatment.
A study found that family members of patients following the Mediterranean diet-based PREDIMED-Plus program experienced significant weight loss, averaging almost 4 kg over two years. Improved dietary habits were also observed, with family members showing increased commitment to the Mediterranean diet.
A study by physicians from IMIM found that administering zinc to COVID-19 patients with low zinc levels can reduce mortality and recovery time, while also preventing severe effects in at-risk groups. The study revealed a direct link between higher zinc levels and reduced risk of death from COVID-19.
A study found that consuming omega-3 fatty acids from both animal and vegetable sources strengthens the heart's membranes, improving prognosis in patients after a heart attack. High levels of these fats at admission were associated with lower risks of complications and mortality.
A team of researchers has discovered that neural networks relevant to memory and learning are over-activated and connectivity is poor in mice with Down syndrome. Chronic treatment with epigallocatechin gallate improves memory deficits. The study identifies biomarkers in brain rhythms that can predict memory deficits.
Research from the Hospital del Mar Medical Research Institute found that high levels of environmental noise increase ischaemic stroke severity, while exposure to green spaces reduces the risk. The study analyzed nearly 3,000 patients and showed a 30% higher risk for those living in noisier areas.
A new drug, TAK-228, has demonstrated effectiveness in treating metastatic bladder cancer, slowing tumor growth and progression. The study found that four of seven patients showed a positive response to the treatment.
Researchers identified a set of genetic variants associated with poorer stroke recovery in patients. The study, involving over 2,000 patients, found that certain variants of the PATJ gene predispose individuals to worse outcomes after a stroke, resulting in significant disability and dependence.
A study published in Nature Communications reveals that inhibiting Jagged 1 protein can prevent colon and rectal tumour growth, even removing existing tumours. This approach may offer a promising therapeutic strategy for selectively targeting malignant stem cells in colon cancer.
The study found that only 27.6% of individuals with anxiety disorders received appropriate treatment, with the remaining cases receiving inadequate care. The low treatment rate is attributed to factors such as lack of awareness, health system weaknesses, and stigma surrounding mental illnesses.
A study of 54,446 people found that obesity significantly increases the risk of suffering from both cancer and heart disease. Women are particularly vulnerable, with a 12 times greater risk of cancer and 5 times higher risk of cardiovascular disease compared to those with a normal weight.
Researchers have identified 6,000 families of genes exclusive to mammals, which play a crucial role in defining their unique characteristics. These genes are involved in the structure of skin, mammary glands, and defense against pathogens.
A six-year study of nearly 1 million people found that autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel diseases increase cardiovascular risk and mortality. The study's results highlight the need for better tools to predict cardiovascular events in these populations.
Researchers at IMIM have found that immunoglobulin M plays a crucial role in regulating the diversity of intestinal flora, including beneficial microorganisms. The study highlights IgM's participation in an immunological memory system, enabling organisms to adapt to their microbial environment.
A study published in the New England Journal of Medicine reveals a genetic mutation that makes bone vulnerable to bisphosphonates, increasing the risk of atypical femur fractures. The discovery highlights the need for personalized treatment approaches to prevent this complication.
Researchers have found that cholesterol can regulate the activity of the adenosine receptor by accessing its active site, potentially leading to new treatments for diseases such as Alzheimer's. This discovery could also have implications for other central nervous system diseases where GPCRs play a key role.